Market Place
Sourcing Support
Evogene Reports Receipt Of Nasdaq Minimum Bid Price Notification
02 Apr 2026 //
PR NEWSWIRE
Evogene Showcases Pharma Discoveries At Bio-Europe Spring 2026
09 Mar 2026 //
PR NEWSWIRE
Evogene Releases CEO Letter To Shareholders
25 Feb 2026 //
PR NEWSWIRE
Evogene Plans 2025 Q4 And Full Year Financial Results Release
19 Feb 2026 //
PR NEWSWIRE
Evogene And (QUT) Partner To Advance AI Cancer Therapeutics
17 Feb 2026 //
PR NEWSWIRE
Evogene, Systasy & LMU Munich Partner on Neutrophil Research
11 Feb 2026 //
PR NEWSWIRE
Evogene Expands Google Cloud AI Collaboration for ChemPass
10 Feb 2026 //
PR NEWSWIRE
Evogene Announces $3.4M Warrant Inducement Deal
10 Feb 2026 //
PR NEWSWIRE
Evogene Appoints Professors Irwin And Major To Scientific
09 Feb 2026 //
PR NEWSWIRE
Evogene & Lishan Bio Announce Licensing Agreement for BMC128
04 Feb 2026 //
PR NEWSWIRE
Evogene, Unravel Biosciences Partner To Develop Novel Therapy
07 Jan 2026 //
PR NEWSWIRE
Evogene Names Dr. Olga Nissan VP Of Business Development
30 Dec 2025 //
PR NEWSWIRE
Evogene Reports Third Quarter 2025 Financial Results
20 Nov 2025 //
PR NEWSWIRE
Evogene Schedules Third Quarter 2025 Financial Results Release
06 Nov 2025 //
PR NEWSWIRE
Evogene to Present at HC Wainwright Global Investment Conference
28 Aug 2025 //
PR NEWSWIRE
Evogene Announces Q2 2025 Financial Results
19 Aug 2025 //
PR NEWSWIRE
Evogene Finalizes Sale of Lavie Bio`s Activity to ICL
09 Jul 2025 //
PR NEWSWIRE
ICL to Acquire the Activity of Evogene`s Subsidiary, Lavie Bio
21 Apr 2025 //
PR NEWSWIRE
Evogene and Verb Biotics Enter Agreement to Advance Probiotic Innovation
06 Feb 2024 //
PR NEWSWIRE
Evogene unit files for EPA approval of bio-fungicide LAV.311 for fruit rots
12 Oct 2022 //
SEEKING ALPHA
Canonic Announces Shipment of its Cannabis Varieties to Europe
31 Jan 2022 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.